
Harnessing Genetics for Hypertrophic Cardiomyopathy 15: A Path to Precision Medicine
Unlock the role of genetic testing in diagnosing and managing Hypertrophic Cardiomyopathy 15. Explore personalized medicine and family risk assessment strategies.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Unlock the role of genetic testing in diagnosing and managing Hypertrophic Cardiomyopathy 15. Explore personalized medicine and family risk assessment strategies.

Explore how genetic testing identifies SCN4A gene mutations, aiding in the diagnosis, management, and personalized treatment of hypokalemic periodic paralysis.

Unravel ARHR2 with genetic testing insights. Early diagnosis aids in symptom management and family planning, improving life quality for those with this rare disorder.

Genetic testing reveals risk factors for IBD28, aiding personalized treatment strategies by identifying mutations, guiding therapy choices, and predicting disease progression.

Explore the role of genetic testing in diagnosing and managing IDAR13. Learn about early detection, family planning, and personalized care for improved outcomes.

Explore how genetic testing identifies PAX6 mutations in Isolated Microphthalmia 4, aiding diagnosis, personalized treatments, and insightful genetic counseling.

Unlock the role of genetic testing in diagnosing Leber Congenital Amaurosis 14, a rare retinal disorder, and explore potential treatments and disease management strategies.

Explore how genetic testing identifies susceptibility to leprosy recurrence, allowing personalized treatment plans and preventive strategies for improved management.